Markets:

Overview

News

Currencies

International

Treasuries

Edwards Lifesciences (NY:EW)

91.18 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EDT, Jun 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Edwards Lifesciences

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Where Edwards Lifesciences Stands With Analysts ↗

December 09, 2021

Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW)...

Via Benzinga

10 Biggest Price Target Changes For Thursday ↗

December 09, 2021

SVB Leerink boosted the price target on Edwards Lifesciences Corporation (NYSE:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2021 ↗

December 06, 2021

Upgrades According to TD Securities, the prior rating for MAG Silver Corp (AMEX:

Via Benzinga

Expert Ratings For Edwards Lifesciences ↗

October 28, 2021

Edwards Lifesciences (NYSE:EW) has observed the following analyst ratings withi...

Via Benzinga

Notable Edwards Lifesciences Insider Trades $4.9M In Company Stock ↗

November 10, 2021

Michael Mussallem, Chairman And CEO at Edwards Lifesciences (NYSE:EW), made a large buy and sell of company shares on November 9, according to a new SEC filing. What Happened: A...

Via Benzinga

Topics Regulatory Compliance

Edwards' Transcatheter Tricuspid Replacement System Shows Favorable Patient Outcomes ↗

November 08, 2021

Edwards Lifesciences Corporation (NYSE: EW) announced results from the TRISCEND study of its EVOQUE transcatheter tricuspid valve replacement system. Patients...

Via Benzinga

Edwards Lifesciences Says Delta Variant Drove Procedure Deferrals In Q3 ↗

October 28, 2021

Edwards Lifesciences Corp (NYSE: EW) reported Q3 earnings of $340.1 million, or $0.54 per share, ahead of the consensus of $0.53. Sales grew 15% to $1.31 billion;...

Via Benzinga

The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug ↗

October 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Corvus' China Partner Approved For Early Stage Study Of CPI-818 In...

Via Benzinga

Earnings Scheduled For October 27, 2021 ↗

October 27, 2021

Companies Reporting Before The Bell • McDonald's (NYSE:MCD) is expected to report quarterly earnings at $2.46 per share on revenue of $6.03 billion. • General...

Via Benzinga

Where Edwards Lifesciences Stands With Analysts ↗

August 21, 2021

Analysts have provided the following ratings for Edwards Lifesciences (NYSE:

Via Benzinga

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline ↗

August 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Edwards Lifesciences Corporation (EW) Q3 2021 Earnings Call Transcript ↗

October 27, 2021

EW earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Recap: Edwards Lifesciences Q3 Earnings ↗

October 27, 2021

Edwards Lifesciences (NYSE:EW) reported its Q3 earnings results on Wednesday, October 27, 2021 at 04:15 PM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Edwards Topples As Full-Year Guidance Comes In Light After Mixed Quarter ↗

October 27, 2021

The company retained guidance for adjusted profit of $2.07-$2.27, missing the midpoint of analysts' view.

Via Investor's Business Daily

Notable Edwards Lifesciences Insider Trades $4.6M In Company Stock ↗

October 04, 2021

Michael Mussallem, Chairman And CEO at Edwards Lifesciences (NYSE:EW), made a large buy and sell of company shares on October 1, according to a new SEC filing. What Happened: A...

Via Benzinga

Topics Regulatory Compliance

Insider Development Of Edwards Lifesciences Trades $1.59 Million In Company Stock ↗

September 13, 2021

Donald Bobo Jr, insider at Edwards Lifesciences (NYSE:EW), made a large buy and sell of company shares on September 10, according to a new SEC filing. What Happened: A Form 4...

Via Benzinga

Topics Regulatory Compliance

Unusual Options Activity Insight: Edwards Lifesciences ↗

August 10, 2021

Edwards Lifesciences (NYSE:EW) shares experienced unusual opt...

Via Benzinga

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO ↗

August 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More ↗

October 24, 2021

Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength...

Via Benzinga

Notable Edwards Lifesciences Insider Trades $1.39 Million In Company Stock ↗

September 09, 2021

Catherine Szyman, Insider at Edwards Lifesciences (NYSE:EW), made a large buy and sell of company shares on September 8, according to a new SEC filing. What Happened: A Form...

Via Benzinga

Topics Regulatory Compliance

The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization ↗

September 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:...

Via Benzinga

'Fast Money Halftime Report' Picks For August 17 ↗

August 17, 2021

On CNBC's "Fast Money Halftime Report," Josh Brown said Chipotle Mexican Grill, Inc. (NYSE: CMG) looks really strong on a weak tape. He likes the stock. Joe...

Via Benzinga

The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod ↗

September 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc...

Via Benzinga

The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself ↗

September 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:...

Via Benzinga

The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal ↗

August 24, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 23) AbbVie Inc. (NYSE: ABBV) (...

Via Benzinga

Stocks That Hit 52-Week Highs On Monday ↗

August 23, 2021

Before 10 a.m. ET on Monday, 119 companies hit new 52-week highs. Noteables: The largest company by market cap to set a new 52-week high was Alphabet (NASDAQ:GOOG...

Via Benzinga

Stocks That Hit 52-Week Highs On Friday ↗

August 20, 2021

Before 10 a.m. ET on Friday, 52 companies hit new 52-week highs. Highlights: Microsoft (NASDAQ:MSFT) was the biggest company by market cap to set a new 52-week high...

Via Benzinga

The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data ↗

August 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS...

Via Benzinga

The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts ↗

August 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (...

Via Benzinga

The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO ↗

August 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)...

Via Benzinga

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Edwards Lifesciences (NY:EW)

All News about Edwards Lifesciences

Starting at $3.75/week.

Subscribe Today